Clinical tumor sequencing: an incidental casualty of the American College of Medical Genetics and Genomics recommendations for reporting of incidental findings.
作者信息
Parsons D Williams, Roy Angshumoy, Plon Sharon E, Roychowdhury Sameek, Chinnaiyan Arul M
机构信息
Baylor College of Medicine and Texas Children's Cancer Center, Houston, TX
Baylor College of Medicine and Texas Children's Cancer Center, Houston, TX.
出版信息
J Clin Oncol. 2014 Jul 20;32(21):2203-5. doi: 10.1200/JCO.2013.54.8917. Epub 2014 Jun 23.
Abstract
摘要
相似文献
1
Clinical tumor sequencing: an incidental casualty of the American College of Medical Genetics and Genomics recommendations for reporting of incidental findings.临床肿瘤测序：美国医学遗传学与基因组学学会关于报告偶发发现的建议的意外牺牲品。
J Clin Oncol. 2014 Jul 20;32(21):2203-5. doi: 10.1200/JCO.2013.54.8917. Epub 2014 Jun 23.
2
Recommendations for returning genomic incidental findings? We need to talk!关于如何报告基因组偶然发现的建议？我们需要谈谈！
Genet Med. 2013 Nov;15(11):854-9. doi: 10.1038/gim.2013.113. Epub 2013 Aug 1.
3
ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).ACMG SF v3.2 临床外显子组和基因组测序中报告次要发现的列表：美国医学遗传学与基因组学学会 (ACMG) 的政策声明。
Genet Med. 2023 Aug;25(8):100866. doi: 10.1016/j.gim.2023.100866. Epub 2023 Jun 22.
4
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).临床外显子组和基因组测序中次要发现报告的建议，2021年更新：美国医学遗传学与基因组学学会（ACMG）政策声明
Genet Med. 2021 Aug;23(8):1391-1398. doi: 10.1038/s41436-021-01171-4. Epub 2021 May 20.
5
ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).美国医学遗传学与基因组学学会（ACMG）关于临床外显子组和基因组测序中次要发现报告的ACMG SF v3.1清单：一项政策声明
Genet Med. 2022 Jul;24(7):1407-1414. doi: 10.1016/j.gim.2022.04.006. Epub 2022 Jun 17.
6
Returning incidental findings in African genomics research.非洲基因组学研究中的偶发发现的返还。
Nat Genet. 2020 Jan;52(1):17-20. doi: 10.1038/s41588-019-0542-4.
7
Point-counterpoint. Ethics and genomic incidental findings.针锋相对。伦理学与基因组偶然发现
Science. 2013 May 31;340(6136):1047-8. doi: 10.1126/science.1240156. Epub 2013 May 16.
8
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.ACMG 临床外显子组和基因组测序中偶然发现报告的推荐标准。
Genet Med. 2013 Jul;15(7):565-74. doi: 10.1038/gim.2013.73. Epub 2013 Jun 20.
9
ACMG recommendations on incidental findings are flawed scientifically and ethically.美国医学遗传学与基因组学学会（ACMG）关于偶发发现的建议在科学和伦理方面存在缺陷。
Genet Med. 2013 Sep;15(9):750-1. doi: 10.1038/gim.2013.96.
10
Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.临床测序探索研究联盟中基因组序列数据中可操作基因的识别的过程和初步结果。
Genet Med. 2013 Nov;15(11):860-7. doi: 10.1038/gim.2013.133. Epub 2013 Oct 24.
引用本文的文献
1
Development of a novel measure of advanced cancer patients' perceived utility of secondary germline findings from tumor genomic profiling.一种针对晚期癌症患者对肿瘤基因组分析中二级胚系结果的感知效用的新型测量方法的开发。
PEC Innov. 2023 Jan 19;2:100124. doi: 10.1016/j.pecinn.2023.100124. eCollection 2023 Dec.
2
Ovarian cancer risk assessment in the era of next-generation sequencing.下一代测序时代的卵巢癌风险评估
Ann Transl Med. 2020 Dec;8(24):1704. doi: 10.21037/atm-20-1582.
3
Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient Perceptions.转移性乳腺癌临床基因组检测的前瞻性决策分析研究：对结局和患者认知的影响
JCO Precis Oncol. 2019 Nov 18;3. doi: 10.1200/PO.19.00090. eCollection 2019.
4
Decision-Making Preferences About Secondary Germline Findings That Arise From Tumor Genomic Profiling Among Patients With Advanced Cancers.晚期癌症患者中肿瘤基因组分析产生的二级胚系发现的决策偏好
JCO Precis Oncol. 2017;1. doi: 10.1200/PO.17.00182. Epub 2017 Dec 21.
5
Identification of a secondary mutation in a pediatric patient with relapsed acute myeloid leukemia leads to the diagnosis and treatment of asymptomatic metastatic medullary thyroid cancer in a parent: a case for sequencing the germline.一名复发性急性髓系白血病儿科患者中发现的二次突变，促成了对其父母无症状转移性甲状腺髓样癌的诊断和治疗：这是一个对种系进行测序的病例。
Cold Spring Harb Mol Case Stud. 2019 Apr 1;5(2). doi: 10.1101/mcs.a003889. Print 2019 Apr.
6
Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer.癌症的药物基因组学和多基因检测的保险覆盖政策。
J Pers Med. 2018 May 16;8(2):19. doi: 10.3390/jpm8020019.
7
Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic Profiling.晚期癌症患者对肿瘤基因组分析中二级胚系发现的兴趣和态度
J Oncol Pract. 2017 Jul;13(7):e590-e601. doi: 10.1200/JOP.2016.020057. Epub 2017 Jun 19.
8
Precision medicine in pediatric oncology: Lessons learned and next steps.儿科肿瘤学中的精准医学：经验教训与下一步措施。
Pediatr Blood Cancer. 2017 Mar;64(3). doi: 10.1002/pbc.26288. Epub 2016 Oct 17.
9
TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.肿瘤下一步检测：一种全面的肿瘤分析检测方法，它结合了高分辨率拷贝数分析和种系状态分析以提高检测准确性。
Oncotarget. 2016 Oct 18;7(42):68206-68228. doi: 10.18632/oncotarget.11910.
10
Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience.患者/家长对儿童实体瘤基因组肿瘤分析的看法：个体化癌症治疗（iCat）经验
Pediatr Blood Cancer. 2016 Nov;63(11):1974-82. doi: 10.1002/pbc.26137. Epub 2016 Jul 18.
本文引用的文献
1
Clinical whole-exome sequencing for the diagnosis of mendelian disorders.临床全外显子测序用于孟德尔疾病的诊断。
N Engl J Med. 2013 Oct 17;369(16):1502-11. doi: 10.1056/NEJMoa1306555. Epub 2013 Oct 2.
2
Actionable, pathogenic incidental findings in 1,000 participants' exomes.1000 名参与者外显子组中的可操作、致病性偶然发现。
Am J Hum Genet. 2013 Oct 3;93(4):631-40. doi: 10.1016/j.ajhg.2013.08.006. Epub 2013 Sep 19.
3
Paternalism and the ACMG recommendations on genomic incidental findings: patients seen but not heard.家长主义与美国医学遗传学与基因组学学会关于基因组偶然发现的建议：患者被看到却未被倾听。
Genet Med. 2013 Sep;15(9):751-2. doi: 10.1038/gim.2013.105.
4
ACMG recommendations on incidental findings are flawed scientifically and ethically.美国医学遗传学与基因组学学会（ACMG）关于偶发发现的建议在科学和伦理方面存在缺陷。
Genet Med. 2013 Sep;15(9):750-1. doi: 10.1038/gim.2013.96.
5
Revealing the incidentalome when targeting the tumor genome.靶向肿瘤基因组时揭示偶发瘤
JAMA. 2013 Aug 28;310(8):795-6. doi: 10.1001/jama.2013.276573.
6
Recommendations for returning genomic incidental findings? We need to talk!关于如何报告基因组偶然发现的建议？我们需要谈谈！
Genet Med. 2013 Nov;15(11):854-9. doi: 10.1038/gim.2013.113. Epub 2013 Aug 1.
7
ACMG clinical laboratory standards for next-generation sequencing.美国医学遗传学与基因组学学会临床实验室标准：下一代测序。
Genet Med. 2013 Sep;15(9):733-47. doi: 10.1038/gim.2013.92. Epub 2013 Jul 25.
8
Return of individual research results and incidental findings: facing the challenges of translational science.个体研究结果和偶然发现的返还：直面转化科学的挑战。
Annu Rev Genomics Hum Genet. 2013;14:557-77. doi: 10.1146/annurev-genom-091212-153506. Epub 2013 Jul 15.
9
Who's on first in exome and whole genome sequencing? Is it the patient or the incidental findings?在全外显子组测序和全基因组测序中，谁占主导地位？是患者还是偶然发现的结果？
Mol Genet Metab. 2013 Sep-Oct;110(1-2):1-2. doi: 10.1016/j.ymgme.2013.06.001. Epub 2013 Jun 7.
10
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.ACMG 临床外显子组和基因组测序中偶然发现报告的推荐标准。
Genet Med. 2013 Jul;15(7):565-74. doi: 10.1038/gim.2013.73. Epub 2013 Jun 20.
Zotero 插件